{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:22:53Z","timestamp":1770787373949,"version":"3.50.0"},"reference-count":10,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.5858\/arpa.2014-0522-le","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T12:26:36Z","timestamp":1438345596000},"page":"969","source":"Crossref","is-referenced-by-count":8,"title":["Standardized Molecular Monitoring for Variant BCR-ABL1 Transcripts in Chronic Myeloid Leukemia"],"prefix":"10.5858","volume":"139","author":[{"given":"Stephen E.","family":"Langabeer","sequence":"first","affiliation":[{"name":"Cancer Molecular Diagnostics, St James's Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"8","key":"i1543-2165-139-8-969-b01","series-title":"Blood","first-page":"3330","article-title":"Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials","volume":"112","author":"Branford\n              S,","year":"2008","unstructured":"Branford\n              S, \n            \n              Fletcher\n              L, \n            \n              Cross\n              NC, \n            et al\n          . Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood. 2008;112(8):3330\u20133338."},{"issue":"22","key":"i1543-2165-139-8-969-b02","series-title":"Blood","first-page":"e111","article-title":"Establishment of the World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA","volume":"116","author":"White\n              HE,","year":"2010","unstructured":"White\n              HE, \n            \n              Matejtschuk\n              P, \n            \n              Rigsby\n              P, \n            et al\n          . Establishment of the World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood. 2010;116(22):e111\u2013e117."},{"key":"i1543-2165-139-8-969-b03","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2013-0754-OA","article-title":"Conversion, correction, and international scale standardization: results from a multicenter external quality assessment study for BCR-ABL1 testing","author":"Griffiths\n              M,","year":"2014]","unstructured":"Griffiths\n              M, \n            \n              Patton\n              SJ, \n            \n              Grossi\n              A, \n            \n              Clark\n              J, \n            \n              Fe Paz\n              M, \n            \n              Labourier\n              E; \n            for Labceutics International BCR-ABL1 Standardization Study Group. \n          Conversion, correction, and international scale standardization: results from a multicenter external quality assessment study for BCR-ABL1 testing\n          [published online ahead of print\n          July\n          25\n          2014]. Arch Pathol Lab Med. doi: 10.5858\/arpa.2013-0754-OA."},{"issue":"13\u201314","key":"i1543-2165-139-8-969-b04","series-title":"Clin Biochem","first-page":"1333","article-title":"Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale","volume":"47","author":"Maut\u00e9\n              C,","year":"2014","unstructured":"Maut\u00e9\n              C, \n            \n              Nibourel\n              O, \n            \n              R\u00e9a\n              D, \n            et al\n          . Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale. Clin Biochem. 2014;47(13\u201314):1333\u20131336."},{"issue":"2","key":"i1543-2165-139-8-969-b05","series-title":"Clin Cancer Res","first-page":"310","article-title":"Deep molecular response in chronic myeloid leukemia: the new goal of therapy?","volume":"20","author":"Mahon\n              FX,","year":"2014","unstructured":"Mahon\n              FX, \n            \n              Etienne\n              G.\n            \n          \n          Deep molecular response in chronic myeloid leukemia: the new goal of therapy?\n          Clin Cancer Res. 2014;20(2):310\u2013322."},{"issue":"8","key":"i1543-2165-139-8-969-b01","series-title":"Blood","first-page":"3330","article-title":"Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials","volume":"112","author":"Branford\n              S,","year":"2008","unstructured":"Branford\n              S, \n            \n              Fletcher\n              L, \n            \n              Cross\n              NC, \n            et al\n          . Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood. 2008;112(8):3330\u20133338."},{"issue":"22","key":"i1543-2165-139-8-969-b02","series-title":"Blood","first-page":"e111","article-title":"Establishment of the World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA","volume":"116","author":"White\n              HE,","year":"2010","unstructured":"White\n              HE, \n            \n              Matejtschuk\n              P, \n            \n              Rigsby\n              P, \n            et al\n          . Establishment of the World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood. 2010;116(22):e111\u2013e117."},{"key":"i1543-2165-139-8-969-b03","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2013-0754-OA","article-title":"Conversion, correction, and international scale standardization: results from a multicenter external quality assessment study for BCR-ABL1 testing","author":"Griffiths\n              M,","year":"2014]","unstructured":"Griffiths\n              M, \n            \n              Patton\n              SJ, \n            \n              Grossi\n              A, \n            \n              Clark\n              J, \n            \n              Fe Paz\n              M, \n            \n              Labourier\n              E; \n            for Labceutics International BCR-ABL1 Standardization Study Group. \n          Conversion, correction, and international scale standardization: results from a multicenter external quality assessment study for BCR-ABL1 testing\n          [published online ahead of print\n          July\n          25\n          2014]. Arch Pathol Lab Med. doi: 10.5858\/arpa.2013-0754-OA."},{"issue":"13\u201314","key":"i1543-2165-139-8-969-b04","series-title":"Clin Biochem","first-page":"1333","article-title":"Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale","volume":"47","author":"Maut\u00e9\n              C,","year":"2014","unstructured":"Maut\u00e9\n              C, \n            \n              Nibourel\n              O, \n            \n              R\u00e9a\n              D, \n            et al\n          . Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale. Clin Biochem. 2014;47(13\u201314):1333\u20131336."},{"issue":"2","key":"i1543-2165-139-8-969-b05","series-title":"Clin Cancer Res","first-page":"310","article-title":"Deep molecular response in chronic myeloid leukemia: the new goal of therapy?","volume":"20","author":"Mahon\n              FX,","year":"2014","unstructured":"Mahon\n              FX, \n            \n              Etienne\n              G.\n            \n          \n          Deep molecular response in chronic myeloid leukemia: the new goal of therapy?\n          Clin Cancer Res. 2014;20(2):310\u2013322."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/8\/article-p969-s.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/139\/8\/969\/1614397\/arpa_2014-0522-le.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/139\/8\/article-p969-s.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/139\/8\/article-p969-s.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:05:49Z","timestamp":1770771949000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/139\/8\/article-p969-s.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":10,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2014-0522-le","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}